Vitrolife further strengthens its sales organization

Vitrolife has employed Jonas Falk as the new Director of Sales and Key Account Marketing for the European and Asian regions. “This is yet another part of our strong market drive to be able to provide direct support for and direct marketing efforts at more clinics,” says Vitrolife’s CEO, Magnus Nilsson.

Jonas Falk has many years of experience in the pharmaceuticals industry and has worked at Pfizer, Hässle Pharmaceuticals and Astra Zeneca. In his most recent position, he worked as Assistant Director National Sales at Astra Zeneca, where he was responsible for training and coordination of sales of Crestor. “It feels inspiring to begin working at Vitrolife as the company has an exciting product portfolio and interesting development projects, and is enjoying strong growth”, says Jonas Falk. Jonas takes up his position during the next few days and will report to the Sales Director, Christer de Flon. October 25, 2005 Kungsbacka, Sweden Magnus Nilsson CEO Questions should be addressed to: Magnus Nilsson, CEO, phone +46 31 721 80 00 or +46 708 22 80 61. Anna Ahlberg, CFO, phone +46 31 721 80 13 or +46 708 22 80 13.

About Us

Vitrolife is an international medical device Group. The Fertility product area develops, produces and markets medical devices for assisted reproduction. Work is also carried out to enable the use and handling of stem cells for therapeutic purposes. Vitrolife has approximately 330 employees and the company’s products are sold in about 110 markets. The company is headquartered in Gothenburg, Sweden, and there are also offices in USA, Australia, France, Italy, United Kingdom, China, Japan, Hungary and Denmark. The Vitrolife share is listed on NASDAQ OMX Stockholm, Mid Cap.

Subscribe

Documents & Links